Upgrade to SI Premium - Free Trial

TG Therapeutics (TGTX) PT Raised to $40 at Ladenburg Thalmann

May 2, 2024 6:34 AM
Ladenburg Thalmann analyst Matthew Kaplan raised the price target on TG Therapeutics (NASDAQ: TGTX) to $40.00 (from $39.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles